Sara Zarougui

503 total citations
19 papers, 370 citations indexed

About

Sara Zarougui is a scholar working on Computational Theory and Mathematics, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Sara Zarougui has authored 19 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Computational Theory and Mathematics, 11 papers in Molecular Biology and 10 papers in Organic Chemistry. Recurrent topics in Sara Zarougui's work include Computational Drug Discovery Methods (15 papers), Synthesis and biological activity (10 papers) and Cancer therapeutics and mechanisms (3 papers). Sara Zarougui is often cited by papers focused on Computational Drug Discovery Methods (15 papers), Synthesis and biological activity (10 papers) and Cancer therapeutics and mechanisms (3 papers). Sara Zarougui collaborates with scholars based in Morocco, Saudi Arabia and Palestinian Territory. Sara Zarougui's co-authors include Mohamed El fadili, Mohammed Er-rajy, Menana Elhallaoui, Somdutt Mujwar, Hamada Imtara, Mohammed Kara, Omkulthom Al kamaly, Amine Assouguem, Hanine Hadni and Wafa Ali Eltayb and has published in prestigious journals such as Scientific Reports, Arabian Journal of Chemistry and Frontiers in Chemistry.

In The Last Decade

Sara Zarougui

19 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Zarougui Morocco 12 177 168 133 58 54 19 370
Mohammed Er-rajy Morocco 13 202 1.1× 195 1.2× 154 1.2× 71 1.2× 72 1.3× 36 458
Williams Jorge da Cruz Macêdo Brazil 13 225 1.3× 200 1.2× 142 1.1× 74 1.3× 39 0.7× 23 493
Elenilze F. B. Ferreira Brazil 10 129 0.7× 124 0.7× 79 0.6× 54 0.9× 38 0.7× 16 317
Ibrahim Olaide Adedotun Nigeria 8 189 1.1× 133 0.8× 171 1.3× 40 0.7× 28 0.5× 18 454
Raí C. Silva Brazil 12 180 1.0× 122 0.7× 132 1.0× 79 1.4× 36 0.7× 18 386
Hanine Hadni Morocco 13 261 1.5× 245 1.5× 151 1.1× 35 0.6× 35 0.6× 26 472
Josivan da Silva Costa Brazil 11 149 0.8× 128 0.8× 87 0.7× 56 1.0× 19 0.4× 17 318
Rahul D. Jawarkar India 13 236 1.3× 281 1.7× 178 1.3× 61 1.1× 17 0.3× 75 568
Amal Alharbi Saudi Arabia 12 73 0.4× 273 1.6× 272 2.0× 53 0.9× 35 0.6× 22 486
Damilola A. Omoboyowa Nigeria 12 110 0.6× 65 0.4× 135 1.0× 37 0.6× 36 0.7× 65 402

Countries citing papers authored by Sara Zarougui

Since Specialization
Citations

This map shows the geographic impact of Sara Zarougui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Zarougui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Zarougui more than expected).

Fields of papers citing papers by Sara Zarougui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Zarougui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Zarougui. The network helps show where Sara Zarougui may publish in the future.

Co-authorship network of co-authors of Sara Zarougui

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Zarougui. A scholar is included among the top collaborators of Sara Zarougui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Zarougui. Sara Zarougui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Er-rajy, Mohammed, Mohamed El fadili, Radwan Alnajjar, et al.. (2025). An in-depth study of indolone derivatives as potential lung cancer treatment. Scientific Reports. 15(1). 2199–2199. 1 indexed citations
2.
fadili, Mohamed El, et al.. (2025). In silico design of novel pyridazine derivatives as balanced multifunctional agents against Alzheimer’s disease. Scientific Reports. 15(1). 15910–15910. 2 indexed citations
3.
Er-rajy, Mohammed, Mohamed El fadili, Sara Zarougui, et al.. (2025). Design and evaluation of novel triazole derivatives as potential anti-gout inhibitors: a comprehensive molecular modeling study. Frontiers in Chemistry. 13. 1518777–1518777. 4 indexed citations
5.
Zarougui, Sara, Mohammed Er-rajy, Hamada Imtara, et al.. (2024). 3D computer modeling of inhibitors targeting the MCF-7 breast cancer cell line. Frontiers in Chemistry. 12. 1384832–1384832. 5 indexed citations
6.
Er-rajy, Mohammed, Mohamed El fadili, Somdutt Mujwar, Sara Zarougui, & Menana Elhallaoui. (2023). Design of novel anti-cancer drugs targeting TRKs inhibitors based 3D QSAR, molecular docking and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics. 41(21). 11657–11670. 40 indexed citations
7.
9.
Er-rajy, Mohammed, Hamada Imtara, Sara Zarougui, et al.. (2023). QSAR modelling, molecular docking, molecular dynamic and ADMET prediction of pyrrolopyrimidine derivatives as novel Bruton’s tyrosine kinase (BTK) inhibitors. Saudi Pharmaceutical Journal. 32(1). 101911–101911. 12 indexed citations
10.
Er-rajy, Mohammed, et al.. (2023). QSAR, molecular docking, and molecular dynamics simulation–based design of novel anti-cancer drugs targeting thioredoxin reductase enzyme. Structural Chemistry. 34(4). 1527–1543. 26 indexed citations
11.
fadili, Mohamed El, Mohammed Er-rajy, Mohnad Abdalla, et al.. (2023). In-silico investigations of novel tacrine derivatives potency against Alzheimer's disease. Scientific African. 23. e02048–e02048. 11 indexed citations
12.
fadili, Mohamed El, Mohammed Er-rajy, Wafa Ali Eltayb, et al.. (2023). In-silico screening based on molecular simulations of 3,4-disubstituted pyrrolidine sulfonamides as selective and competitive GlyT1 inhibitors. Arabian Journal of Chemistry. 16(10). 105105–105105. 22 indexed citations
13.
Zarougui, Sara, Mohammed Er-rajy, Hamada Imtara, et al.. (2023). QSAR, DFT studies, docking molecular and simulation dynamic molecular of 2-styrylquinoline derivatives through their anticancer activity. Journal of Saudi Chemical Society. 27(6). 101728–101728. 9 indexed citations
14.
fadili, Mohamed El, Mohammed Er-rajy, Wafa Ali Eltayb, et al.. (2023). An in-silico investigation based on molecular simulations of novel and potential brain-penetrant GluN2B NMDA receptor antagonists as anti-stroke therapeutic agents. Journal of Biomolecular Structure and Dynamics. 42(12). 6174–6188. 23 indexed citations
15.
Er-rajy, Mohammed, Mohamed El fadili, Somdutt Mujwar, et al.. (2023). Design of novel anti-cancer agents targeting COX-2 inhibitors based on computational studies. Arabian Journal of Chemistry. 16(10). 105193–105193. 24 indexed citations
16.
Er-rajy, Mohammed, et al.. (2022). QSAR, molecular docking, ADMET properties in silico studies for a series of 7-propanamide benzoxaboroles as potent anti-cancer agents. Chinese Journal of Analytical Chemistry. 50(12). 100163–100163. 22 indexed citations
18.
19.
fadili, Mohamed El, Mohammed Er-rajy, Hamada Imtara, et al.. (2022). 3D-QSAR, ADME-Tox In Silico Prediction and Molecular Docking Studies for Modeling the Analgesic Activity against Neuropathic Pain of Novel NR2B-Selective NMDA Receptor Antagonists. Processes. 10(8). 1462–1462. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026